Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Antares Pharma, Inc. (NASDAQ: ATRS) today reported operating and financial results for the second quarter ended June 30, 2013.
Quarter and Recent Highlights
•OTREXUP™ development program is on track with anticipated PDUFA date of October 14, 2013.
•Granted product specific U.S. patent 8,480,631 for OTREXUP™.
Hey, check out all the research scientist jobs. Post your resume today!
Antares Pharma, Inc. (NASDAQ: ATRS) today reported operating and financial results for the second quarter ended June 30, 2013.
Quarter and Recent Highlights
•OTREXUP™ development program is on track with anticipated PDUFA date of October 14, 2013.
•Granted product specific U.S. patent 8,480,631 for OTREXUP™.
Hey, check out all the research scientist jobs. Post your resume today!
